MU-1, member of the cytokine receptor family

Details MU-1, member of the cytokine receptor family MU-1, member of the cytokine receptor family

2011-08-09

2011-08-09

Ulm, John (Department: 1649)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C424S172100

Reexamination Certificate

active

07994292

ABSTRACT:
Polynucleotides encoding the MU-1 hematopoietin receptor superfamily chain and fragments thereof are disclosed. MU-1 proteins, antibodies (and fragments thereof) that specifically bind to MU-1 proteins (and fragments thereof), and methods for their production are also disclosed.

REFERENCES:
patent: 5011912 (1991-04-01), Hopp et al.
patent: 5098833 (1992-03-01), Lasky et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5155027 (1992-10-01), Sledziewski et al.
patent: 5216131 (1993-06-01), Lasky et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5447851 (1995-09-01), Beutler et al.
patent: 5455165 (1995-10-01), Capon et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5567584 (1996-10-01), Sledziewski et al.
patent: 5714147 (1998-02-01), Capon et al.
patent: 5750375 (1998-05-01), Sledziewski et al.
patent: 5840844 (1998-11-01), Lasky et al.
patent: 5843725 (1998-12-01), Sledziewski et al.
patent: 6018026 (2000-01-01), Sledziewski et al.
patent: 6057128 (2000-05-01), Donaldson et al.
patent: 6136310 (2000-10-01), Hanna et al.
patent: 6291212 (2001-09-01), Sledziewski et al.
patent: 6291646 (2001-09-01), Sledziewski et al.
patent: 6300099 (2001-10-01), Sledziewski et al.
patent: 6307024 (2001-10-01), Novak et al.
patent: 6323323 (2001-11-01), Sledziewski et al.
patent: 6406697 (2002-06-01), Capon et al.
patent: 6576744 (2003-06-01), Presnell et al.
patent: 6605272 (2003-08-01), Novak et al.
patent: 6686178 (2004-02-01), Novak et al.
patent: 6692924 (2004-02-01), Presnell et al.
patent: 6777539 (2004-08-01), Sprecher et al.
patent: 6803451 (2004-10-01), Presnell
patent: 7189400 (2007-03-01), Carter et al.
patent: 7198789 (2007-04-01), Carter et al.
patent: 7314623 (2008-01-01), Grusby et al.
patent: 7495085 (2009-02-01), Valge-Archer et al.
patent: 2001/0025022 (2001-09-01), Kikly et al.
patent: 2002/0090680 (2002-07-01), Hodge
patent: 2002/0128446 (2002-09-01), Novak et al.
patent: 2002/0137677 (2002-09-01), Sprecher et al.
patent: 2002/0160451 (2002-10-01), Masiakowski et al.
patent: 2003/0134390 (2003-07-01), Presnell et al.
patent: 2003/0148447 (2003-08-01), Presnell et al.
patent: 2004/0016010 (2004-01-01), Kasaian et al.
patent: 2004/0235743 (2004-11-01), Sprecher et al.
patent: 2006/0024268 (2006-02-01), Kasaian et al.
patent: 2006/0039902 (2006-02-01), Young et al.
patent: 2006/0159655 (2006-07-01), Collins et al.
patent: 2006/0257403 (2006-11-01), Young et al.
patent: 2008/0241098 (2008-10-01), Young et al.
patent: 2009/0197803 (2009-08-01), Grusby et al.
patent: 2009/0298081 (2009-12-01), Bloom et al.
patent: 2009/0298167 (2009-12-01), Bloom et al.
patent: 0 812 913 (1997-12-01), None
patent: 1 088 831 (2001-04-01), None
patent: WO 96/04388 (1996-02-01), None
patent: WO 97/20926 (1997-06-01), None
patent: WO 97/31946 (1997-09-01), None
patent: WO 97/33913 (1997-09-01), None
patent: WO 97/47741 (1997-12-01), None
patent: WO 97/47742 (1997-12-01), None
patent: WO 98/10638 (1998-03-01), None
patent: WO 98/11225 (1998-03-01), None
patent: WO 98/31811 (1998-07-01), None
patent: WO 99/47675 (1999-09-01), None
patent: WO 99/67290 (1999-12-01), None
patent: WO 00/08152 (2000-02-01), None
patent: WO 00/17235 (2000-03-01), None
patent: WO 00/27882 (2000-05-01), None
patent: WO 00/53761 (2000-09-01), None
patent: WO 00/69880 (2000-11-01), None
patent: WO 01/36467 (2001-05-01), None
patent: WO 01/46261 (2001-06-01), None
patent: WO 01/77171 (2001-10-01), None
patent: WO 01/85792 (2001-11-01), None
patent: WO 03/040313 (2003-03-01), None
patent: WO 03/028630 (2003-04-01), None
patent: WO 2004/007682 (2004-01-01), None
patent: WO 2004/083249 (2004-09-01), None
patent: WO 2004/084835 (2004-10-01), None
patent: WO 2005/112983 (2005-12-01), None
patent: WO 2006/113331 (2006-10-01), None
patent: WO 2006/135385 (2006-12-01), None
patent: WO 2009/100035 (2009-08-01), None
Cosman “The Hematopoietin Receptor Superfamily”,Cytokine, vol. 5, No. 2, Mar. 1993, pp. 95-106.
Gonda and D'Andrea “Activating Mutations in Cytokine Receptors: Implications for Receptor Function and Role in Disease”,Blood, vol. 89, No. 2, Jan. 1997, pp. 355-369.
Goldsmith et al. “The Cytoplasmic Domain of the Interleukin-2 Receptor β Chain Contains Both Unique and Functionally Redundant Signal Transduction Elements”,J. Biol. Chem., vol. 269, 1994, pp. 14698-14704.
Goldsmith et al. “Growth Signal Transduction by the Human Interleukin-2 Receptor Requires Cytoplasmic Tyrosines of the β Chain and Non-tyrosine Residues of the γc Chain”,J. Biol. Chem., vol. 270, 1995, pp. 21729-21737.
Altschul et al. “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs”,Nuc. Acids Res., vol. 25, No. 17, 1997, pp. 3389-3402.
Frishman et al. “The PEDANT genome database”,Nuc. Acids Res., vol. 31, No. 1, 2003, pp. 207-211.
Brenner et al. “Assessing sequence comparison methods with reliable structurally identified distant evolutionary relationships”,Proc. Natl. Acad. Sci. USA, vol. 95, May 1998, pp. 6073-6078.
Brenner et al. “The ASTRAL compendium for protein structure and sequence analysis”,Nuc. Acids Res., vol. 28, No. 1, 2000, pp. 254-56.
Sander and Schneider “Database of Homology-Derived Protein Structures and the Structural Meaning of Sequence Alignment”,Proteins, vol. 9, 1991, pp. 56-68.
Chung and Subbiah “A structural explanation for the twilight zone of protein sequence homology”,Structure(London), vol. 4, 1996, pp. 1123-1127.
Fitch “An Improved Method of Testing for Evolutionary Homology”,J. Mol. Biol., vol. 16, 1966, pp. 9-16.
Bagley et al. “The Structural and Functional Basis of Cytokine Receptor Activation: Lessons From the Common β Subunit of the Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-3 (IL-3), and IL-5 Receptors”,Blood, vol. 89, No. 5, Mar. 1, 1997, pp. 1471-1482.
Yamasaki et al. “Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor”,Science, vol. 241, Aug. 12, 1988, pp. 825-828.
Somers et al. “1.9 Å crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling”,EMBO J., vol. 16, No. 5, 1997, p. 989-97.
Taga and Kishimoto “Cytokine receptors and signal transduction”,FASEB J., vol. 6, 1992, pp. 3387-3396.
Minami et al. “The IL-2 Receptor Complex: Its Structure, Function, and Target Genes”,Annu. Rev. Immunol., vol. 11, 1993, pp. 245-267.
DiSanto “Cytokines: Shared receptors, distinct functions”, Curr. Biol., vol. 7, 1997, pp. R424-R426.
Vita et al. “Characterization and Comparison of the Interleukin 13 Receptor with the Interleukin 4 Receptor on Several Cell Types”,J. Biol. Chem., vol. 270, No. 8, 1995, pp. 3512-3517.
Uckun et al. “Interleukin 7 receptor ligation stimulates tyrosine phosphorylation, inositol phospholipid turnover, and clonal proliferation of human B-cell precursors”,Proc. Natl. Acad. Sci. USA, vol. 88, May 1991, pp. 3589-3593.
Demoulin et al. “A Single Tyrosine of the Interleukin-9 (IL-9) Receptor is Required for STAT Activation, Antiapoptotic Activity, and Growth Regulation by IL-9”,Mol. Cell. Biol., vol. 16, No. 9, Sep. 1996, pp. 4710-4716.
Leonard and Spolski “Interleukin-21: A Modulator of Lymphoid Proliferation, Apoptosis and Differentiation”, Nat. Rev. Immunol., vol. 5, Sep. 2005, pp. 688-698.
Murakami “Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family”,Proc. Natl. Acad. Sci. USA, vol. 88, Dec. 1991, pp. 11349-11353.
Maliszewski and Fanslow “Soluble receptors for IL-1 and IL-4: biological activity and therapeutic potential”,Trends Biotech., vol. 8, 1990, pp. 324-329.
Hou et al. “Identification and Purification of Human Stat Proteins Activated in Response to Interleukin-2”,Immunity, vol. 2, 1995, pp. 321-329.

Affiliated with

Also associated with

Rating

MU-1, member of the cytokine receptor family does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with MU-1, member of the cytokine receptor family, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MU-1, member of the cytokine receptor family will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2682590